Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Artículo | IMSEAR | ID: sea-233563

RESUMEN

A variety of complications came to light after the SARS-CoV-2 pandemic of 2020. One such post-covid complication that manifests itself in the form of a hyperinflammatory syndrome in the pediatric population is multisystem inflammatory syndrome in children (MIS-C). It results in severe inflammation of a variety of organ systems, including the heart, lungs, brain, kidneys, gastrointestinal system, skin, and eyes. Surprisingly, clinicians can easily mistake this type of presentation for many other diseases due to overlapping features, especially Kawasaki disease (KD). An interesting case report on a patient admitted to the Grodno regional infectious diseases clinical hospital, Grodno, Belarus. The patient was initially diagnosed with enteroviral infection (EVI) at the time of admission. The clinicians in charge observed the underlying cause to be masked by Kawasaki-like presentation, how they diagnosed MIS-C, Kawasaki-like phenotype: exanthema, cheilitis, scleritis, infectious cardiopathy, gastrointestinal syndrome, coagulopathy and managed this patient is described in this scientific paper. Although the presenting signs and symptoms of MIS-C overlap with other diseases, certain additional features can be helpful in differentiation. Mainly MIS-C is present in a relatively older subgroup along with gastrointestinal symptoms that are uncommon for KD. The patient was treated with IVIG and steroids after which he attained full recovery. MIS-C associated with COVID-19 is serious, rare, and potentially fatal. Clinicians, primary care physicians, and emergency department pediatricians must be quick to recognize it and treat it at the earliest by deploying immunomodulatory strategies to subdue systemic injury caused by hyper-inflammation.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA